Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence"

Affiliations

Comment

David R Bangsberg et al. JAMA Intern Med. 2013.

. 2013 Feb 25;173(4):306-7.

doi: 10.1001/jamainternmed.2013.2858.

¹ MGH Center for Global Health, 100 Cambridge St, 15th Floor, Boston, MA 02114, USA .dbangsberg@partners.org

No abstract available

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Managed problem solving for antiretroviral therapy adherence: a randomized trial.
Gross R, Bellamy SL, Chapman J, Han X, O'Duor J, Palmer SC, Houts PS, Coyne JC, Strom BL. Gross R, et al. JAMA Intern Med. 2013 Feb 25;173(4):300-6. doi: 10.1001/jamainternmed.2013.2152. JAMA Intern Med. 2013. PMID: 23358784 Free PMC article. Clinical Trial.

1. Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26(3):335–343. - PubMed
1. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155(4):209–216. - PubMed
1. Cohen MS, Chen YQ, McCauley M, et al. HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. - PMC - PubMed
1. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13(suppl 1):82–91. - PubMed
1. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–1121. - PubMed